Alveolar macrophages depletion affects the ability of Dolosigranulum pigrum 040417 to protect infant mice against pneumococcal infection
- Autores
- Raya Tonetti, María Fernanda; Ortiz Moyano, Francisco Ramiro; Tomokiyo, Mikado; Melnikov, Vyacheslav; Kitazawa, Haruki; Villena, Julio Cesar
- Año de publicación
- 2021
- Idioma
- inglés
- Tipo de recurso
- documento de conferencia
- Estado
- versión publicada
- Descripción
- Previously, we demonstrated that the nasal administration of the respiratory commensal bacterium Dolosigranulum pigrum 040417 (Dp04) to infant mice differentially modulates the respiratory immune response triggered by Toll-like receptor (TLR)-2 activation, increasing the resistance to Streptococcus pneumoniae (Sp) infection. The nasal priming with Dp04 reduced pneumococcal counts in lung and blood and diminished the levels of lung injury biomarkers. In this work, we aimed to characterize the role of alveolar macrophages (AM) on the immunomodulatory properties of Dp04 in the context of pneumococcal infection. In the first set of experiments, mice were nasally stimulated with Dp04 (108 cells/mouse/day) for 5 consecutive days and then challenged with 106 CFU of Sp. Variations in numbers and functionality of resident AM in broncho-alveolar lavage (BAL) samples were evaluated. The number of activated CD11c+SiglecF+MHC-IIhi AM was significantly increased after Sp challenge in mice primed with Dp04 than in controls (p<0.05). Furthermore, AM obtained from Dp04-treated mice produced in vitro higher levels of IFN-β and IFN-γ, as well as IL-10 and IL-27 compared to the control group (p<0.05). In a second set of experiments, AM were depleted using liposomes containing clodronate (CLP) before the stimulation of with Dp04. The CLP treatment significantly affected the ability of Dp04 to reduce pneumococcal cell counts, as well as lung injury biomarkers. In addition, AM depletion impaired the capacity of Dp04 to differentially modulate the cytokine profile in the respiratory tract. The ability of Dp04 to increase the levels of BAL IFN-γ, IL-10 and IL-27 in response to Sp infection was abolished when AM were depleted by CLP (p<0.05). This results show for the first time that AM have a relevant role in the immunomodulatory effect of Dp04. Our results also mark a significant advance in the positioning of Dp04 as a next-generation probiotic for the respiratory tract.
Fil: Raya Tonetti, María Fernanda. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Tucumán. Centro de Referencia para Lactobacilos; Argentina
Fil: Ortiz Moyano, Francisco Ramiro. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Tucumán. Centro de Referencia para Lactobacilos; Argentina
Fil: Tomokiyo, Mikado. Tohoku University; Japón
Fil: Melnikov, Vyacheslav. Gabrichevsky Research Institute of Epidemiology and Microbiology; Rusia
Fil: Kitazawa, Haruki. Tohoku University; Japón
Fil: Villena, Julio Cesar. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Tucumán. Centro de Referencia para Lactobacilos; Argentina
LXVI Reunión anual de la Sociedad Argentina de Investigación Clínica (SAIC); LXIX Reunión anual de la Sociedad Argentina de Immunología (SAI); LIII Reunión anual de la Asociación Argentina de Farmacología Experimental (AAFE) y XI Reunión anual de la Asociación Argentina de Nanomedicinas (NANOMED-AR)
Argentina
Sociedad Argentina de Investigación Clínica
Sociedad Argentina de Inmunologia
Asociación Argentina de Farmacología Experimental
Asociación Argentina de Nanomedicinas - Materia
-
ALVEOLAR MACROPHAGES
CLODRONATE LIPOSOMES
RESPIRATORY COMMENSAL BACTERIA
INNATE RESPIRATORY IMMUNITY - Nivel de accesibilidad
- acceso abierto
- Condiciones de uso
- https://creativecommons.org/licenses/by-nc-sa/2.5/ar/
- Repositorio
- Institución
- Consejo Nacional de Investigaciones Científicas y Técnicas
- OAI Identificador
- oai:ri.conicet.gov.ar:11336/158438
Ver los metadatos del registro completo
id |
CONICETDig_bb29ff5f11260adbb2614c3a7962fc74 |
---|---|
oai_identifier_str |
oai:ri.conicet.gov.ar:11336/158438 |
network_acronym_str |
CONICETDig |
repository_id_str |
3498 |
network_name_str |
CONICET Digital (CONICET) |
spelling |
Alveolar macrophages depletion affects the ability of Dolosigranulum pigrum 040417 to protect infant mice against pneumococcal infectionRaya Tonetti, María FernandaOrtiz Moyano, Francisco RamiroTomokiyo, MikadoMelnikov, VyacheslavKitazawa, HarukiVillena, Julio CesarALVEOLAR MACROPHAGESCLODRONATE LIPOSOMESRESPIRATORY COMMENSAL BACTERIAINNATE RESPIRATORY IMMUNITYhttps://purl.org/becyt/ford/3.3https://purl.org/becyt/ford/3Previously, we demonstrated that the nasal administration of the respiratory commensal bacterium Dolosigranulum pigrum 040417 (Dp04) to infant mice differentially modulates the respiratory immune response triggered by Toll-like receptor (TLR)-2 activation, increasing the resistance to Streptococcus pneumoniae (Sp) infection. The nasal priming with Dp04 reduced pneumococcal counts in lung and blood and diminished the levels of lung injury biomarkers. In this work, we aimed to characterize the role of alveolar macrophages (AM) on the immunomodulatory properties of Dp04 in the context of pneumococcal infection. In the first set of experiments, mice were nasally stimulated with Dp04 (108 cells/mouse/day) for 5 consecutive days and then challenged with 106 CFU of Sp. Variations in numbers and functionality of resident AM in broncho-alveolar lavage (BAL) samples were evaluated. The number of activated CD11c+SiglecF+MHC-IIhi AM was significantly increased after Sp challenge in mice primed with Dp04 than in controls (p<0.05). Furthermore, AM obtained from Dp04-treated mice produced in vitro higher levels of IFN-β and IFN-γ, as well as IL-10 and IL-27 compared to the control group (p<0.05). In a second set of experiments, AM were depleted using liposomes containing clodronate (CLP) before the stimulation of with Dp04. The CLP treatment significantly affected the ability of Dp04 to reduce pneumococcal cell counts, as well as lung injury biomarkers. In addition, AM depletion impaired the capacity of Dp04 to differentially modulate the cytokine profile in the respiratory tract. The ability of Dp04 to increase the levels of BAL IFN-γ, IL-10 and IL-27 in response to Sp infection was abolished when AM were depleted by CLP (p<0.05). This results show for the first time that AM have a relevant role in the immunomodulatory effect of Dp04. Our results also mark a significant advance in the positioning of Dp04 as a next-generation probiotic for the respiratory tract.Fil: Raya Tonetti, María Fernanda. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Tucumán. Centro de Referencia para Lactobacilos; ArgentinaFil: Ortiz Moyano, Francisco Ramiro. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Tucumán. Centro de Referencia para Lactobacilos; ArgentinaFil: Tomokiyo, Mikado. Tohoku University; JapónFil: Melnikov, Vyacheslav. Gabrichevsky Research Institute of Epidemiology and Microbiology; RusiaFil: Kitazawa, Haruki. Tohoku University; JapónFil: Villena, Julio Cesar. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Tucumán. Centro de Referencia para Lactobacilos; ArgentinaLXVI Reunión anual de la Sociedad Argentina de Investigación Clínica (SAIC); LXIX Reunión anual de la Sociedad Argentina de Immunología (SAI); LIII Reunión anual de la Asociación Argentina de Farmacología Experimental (AAFE) y XI Reunión anual de la Asociación Argentina de Nanomedicinas (NANOMED-AR)ArgentinaSociedad Argentina de Investigación ClínicaSociedad Argentina de InmunologiaAsociación Argentina de Farmacología ExperimentalAsociación Argentina de NanomedicinasFundación Revista Medicina2021info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/conferenceObjectReuniónJournalhttp://purl.org/coar/resource_type/c_5794info:ar-repo/semantics/documentoDeConferenciaapplication/pdfapplication/vnd.openxmlformats-officedocument.wordprocessingml.documentapplication/pdfhttp://hdl.handle.net/11336/158438Alveolar macrophages depletion affects the ability of Dolosigranulum pigrum 040417 to protect infant mice against pneumococcal infection; LXVI Reunión anual de la Sociedad Argentina de Investigación Clínica (SAIC); LXIX Reunión anual de la Sociedad Argentina de Immunología (SAI); LIII Reunión anual de la Asociación Argentina de Farmacología Experimental (AAFE) y XI Reunión anual de la Asociación Argentina de Nanomedicinas (NANOMED-AR); Argentina; 2021; 142-1420025-76801669-9106CONICET DigitalCONICETenginfo:eu-repo/semantics/altIdentifier/url/https://www.reunionbiociencias.com.ar/wp-content/uploads/2021/11/Revista-Medicina-2021.pdfInternacionalinfo:eu-repo/semantics/openAccesshttps://creativecommons.org/licenses/by-nc-sa/2.5/ar/reponame:CONICET Digital (CONICET)instname:Consejo Nacional de Investigaciones Científicas y Técnicas2025-10-15T15:31:44Zoai:ri.conicet.gov.ar:11336/158438instacron:CONICETInstitucionalhttp://ri.conicet.gov.ar/Organismo científico-tecnológicoNo correspondehttp://ri.conicet.gov.ar/oai/requestdasensio@conicet.gov.ar; lcarlino@conicet.gov.arArgentinaNo correspondeNo correspondeNo correspondeopendoar:34982025-10-15 15:31:44.362CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicasfalse |
dc.title.none.fl_str_mv |
Alveolar macrophages depletion affects the ability of Dolosigranulum pigrum 040417 to protect infant mice against pneumococcal infection |
title |
Alveolar macrophages depletion affects the ability of Dolosigranulum pigrum 040417 to protect infant mice against pneumococcal infection |
spellingShingle |
Alveolar macrophages depletion affects the ability of Dolosigranulum pigrum 040417 to protect infant mice against pneumococcal infection Raya Tonetti, María Fernanda ALVEOLAR MACROPHAGES CLODRONATE LIPOSOMES RESPIRATORY COMMENSAL BACTERIA INNATE RESPIRATORY IMMUNITY |
title_short |
Alveolar macrophages depletion affects the ability of Dolosigranulum pigrum 040417 to protect infant mice against pneumococcal infection |
title_full |
Alveolar macrophages depletion affects the ability of Dolosigranulum pigrum 040417 to protect infant mice against pneumococcal infection |
title_fullStr |
Alveolar macrophages depletion affects the ability of Dolosigranulum pigrum 040417 to protect infant mice against pneumococcal infection |
title_full_unstemmed |
Alveolar macrophages depletion affects the ability of Dolosigranulum pigrum 040417 to protect infant mice against pneumococcal infection |
title_sort |
Alveolar macrophages depletion affects the ability of Dolosigranulum pigrum 040417 to protect infant mice against pneumococcal infection |
dc.creator.none.fl_str_mv |
Raya Tonetti, María Fernanda Ortiz Moyano, Francisco Ramiro Tomokiyo, Mikado Melnikov, Vyacheslav Kitazawa, Haruki Villena, Julio Cesar |
author |
Raya Tonetti, María Fernanda |
author_facet |
Raya Tonetti, María Fernanda Ortiz Moyano, Francisco Ramiro Tomokiyo, Mikado Melnikov, Vyacheslav Kitazawa, Haruki Villena, Julio Cesar |
author_role |
author |
author2 |
Ortiz Moyano, Francisco Ramiro Tomokiyo, Mikado Melnikov, Vyacheslav Kitazawa, Haruki Villena, Julio Cesar |
author2_role |
author author author author author |
dc.subject.none.fl_str_mv |
ALVEOLAR MACROPHAGES CLODRONATE LIPOSOMES RESPIRATORY COMMENSAL BACTERIA INNATE RESPIRATORY IMMUNITY |
topic |
ALVEOLAR MACROPHAGES CLODRONATE LIPOSOMES RESPIRATORY COMMENSAL BACTERIA INNATE RESPIRATORY IMMUNITY |
purl_subject.fl_str_mv |
https://purl.org/becyt/ford/3.3 https://purl.org/becyt/ford/3 |
dc.description.none.fl_txt_mv |
Previously, we demonstrated that the nasal administration of the respiratory commensal bacterium Dolosigranulum pigrum 040417 (Dp04) to infant mice differentially modulates the respiratory immune response triggered by Toll-like receptor (TLR)-2 activation, increasing the resistance to Streptococcus pneumoniae (Sp) infection. The nasal priming with Dp04 reduced pneumococcal counts in lung and blood and diminished the levels of lung injury biomarkers. In this work, we aimed to characterize the role of alveolar macrophages (AM) on the immunomodulatory properties of Dp04 in the context of pneumococcal infection. In the first set of experiments, mice were nasally stimulated with Dp04 (108 cells/mouse/day) for 5 consecutive days and then challenged with 106 CFU of Sp. Variations in numbers and functionality of resident AM in broncho-alveolar lavage (BAL) samples were evaluated. The number of activated CD11c+SiglecF+MHC-IIhi AM was significantly increased after Sp challenge in mice primed with Dp04 than in controls (p<0.05). Furthermore, AM obtained from Dp04-treated mice produced in vitro higher levels of IFN-β and IFN-γ, as well as IL-10 and IL-27 compared to the control group (p<0.05). In a second set of experiments, AM were depleted using liposomes containing clodronate (CLP) before the stimulation of with Dp04. The CLP treatment significantly affected the ability of Dp04 to reduce pneumococcal cell counts, as well as lung injury biomarkers. In addition, AM depletion impaired the capacity of Dp04 to differentially modulate the cytokine profile in the respiratory tract. The ability of Dp04 to increase the levels of BAL IFN-γ, IL-10 and IL-27 in response to Sp infection was abolished when AM were depleted by CLP (p<0.05). This results show for the first time that AM have a relevant role in the immunomodulatory effect of Dp04. Our results also mark a significant advance in the positioning of Dp04 as a next-generation probiotic for the respiratory tract. Fil: Raya Tonetti, María Fernanda. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Tucumán. Centro de Referencia para Lactobacilos; Argentina Fil: Ortiz Moyano, Francisco Ramiro. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Tucumán. Centro de Referencia para Lactobacilos; Argentina Fil: Tomokiyo, Mikado. Tohoku University; Japón Fil: Melnikov, Vyacheslav. Gabrichevsky Research Institute of Epidemiology and Microbiology; Rusia Fil: Kitazawa, Haruki. Tohoku University; Japón Fil: Villena, Julio Cesar. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Tucumán. Centro de Referencia para Lactobacilos; Argentina LXVI Reunión anual de la Sociedad Argentina de Investigación Clínica (SAIC); LXIX Reunión anual de la Sociedad Argentina de Immunología (SAI); LIII Reunión anual de la Asociación Argentina de Farmacología Experimental (AAFE) y XI Reunión anual de la Asociación Argentina de Nanomedicinas (NANOMED-AR) Argentina Sociedad Argentina de Investigación Clínica Sociedad Argentina de Inmunologia Asociación Argentina de Farmacología Experimental Asociación Argentina de Nanomedicinas |
description |
Previously, we demonstrated that the nasal administration of the respiratory commensal bacterium Dolosigranulum pigrum 040417 (Dp04) to infant mice differentially modulates the respiratory immune response triggered by Toll-like receptor (TLR)-2 activation, increasing the resistance to Streptococcus pneumoniae (Sp) infection. The nasal priming with Dp04 reduced pneumococcal counts in lung and blood and diminished the levels of lung injury biomarkers. In this work, we aimed to characterize the role of alveolar macrophages (AM) on the immunomodulatory properties of Dp04 in the context of pneumococcal infection. In the first set of experiments, mice were nasally stimulated with Dp04 (108 cells/mouse/day) for 5 consecutive days and then challenged with 106 CFU of Sp. Variations in numbers and functionality of resident AM in broncho-alveolar lavage (BAL) samples were evaluated. The number of activated CD11c+SiglecF+MHC-IIhi AM was significantly increased after Sp challenge in mice primed with Dp04 than in controls (p<0.05). Furthermore, AM obtained from Dp04-treated mice produced in vitro higher levels of IFN-β and IFN-γ, as well as IL-10 and IL-27 compared to the control group (p<0.05). In a second set of experiments, AM were depleted using liposomes containing clodronate (CLP) before the stimulation of with Dp04. The CLP treatment significantly affected the ability of Dp04 to reduce pneumococcal cell counts, as well as lung injury biomarkers. In addition, AM depletion impaired the capacity of Dp04 to differentially modulate the cytokine profile in the respiratory tract. The ability of Dp04 to increase the levels of BAL IFN-γ, IL-10 and IL-27 in response to Sp infection was abolished when AM were depleted by CLP (p<0.05). This results show for the first time that AM have a relevant role in the immunomodulatory effect of Dp04. Our results also mark a significant advance in the positioning of Dp04 as a next-generation probiotic for the respiratory tract. |
publishDate |
2021 |
dc.date.none.fl_str_mv |
2021 |
dc.type.none.fl_str_mv |
info:eu-repo/semantics/publishedVersion info:eu-repo/semantics/conferenceObject Reunión Journal http://purl.org/coar/resource_type/c_5794 info:ar-repo/semantics/documentoDeConferencia |
status_str |
publishedVersion |
format |
conferenceObject |
dc.identifier.none.fl_str_mv |
http://hdl.handle.net/11336/158438 Alveolar macrophages depletion affects the ability of Dolosigranulum pigrum 040417 to protect infant mice against pneumococcal infection; LXVI Reunión anual de la Sociedad Argentina de Investigación Clínica (SAIC); LXIX Reunión anual de la Sociedad Argentina de Immunología (SAI); LIII Reunión anual de la Asociación Argentina de Farmacología Experimental (AAFE) y XI Reunión anual de la Asociación Argentina de Nanomedicinas (NANOMED-AR); Argentina; 2021; 142-142 0025-7680 1669-9106 CONICET Digital CONICET |
url |
http://hdl.handle.net/11336/158438 |
identifier_str_mv |
Alveolar macrophages depletion affects the ability of Dolosigranulum pigrum 040417 to protect infant mice against pneumococcal infection; LXVI Reunión anual de la Sociedad Argentina de Investigación Clínica (SAIC); LXIX Reunión anual de la Sociedad Argentina de Immunología (SAI); LIII Reunión anual de la Asociación Argentina de Farmacología Experimental (AAFE) y XI Reunión anual de la Asociación Argentina de Nanomedicinas (NANOMED-AR); Argentina; 2021; 142-142 0025-7680 1669-9106 CONICET Digital CONICET |
dc.language.none.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
info:eu-repo/semantics/altIdentifier/url/https://www.reunionbiociencias.com.ar/wp-content/uploads/2021/11/Revista-Medicina-2021.pdf |
dc.rights.none.fl_str_mv |
info:eu-repo/semantics/openAccess https://creativecommons.org/licenses/by-nc-sa/2.5/ar/ |
eu_rights_str_mv |
openAccess |
rights_invalid_str_mv |
https://creativecommons.org/licenses/by-nc-sa/2.5/ar/ |
dc.format.none.fl_str_mv |
application/pdf application/vnd.openxmlformats-officedocument.wordprocessingml.document application/pdf |
dc.coverage.none.fl_str_mv |
Internacional |
dc.publisher.none.fl_str_mv |
Fundación Revista Medicina |
publisher.none.fl_str_mv |
Fundación Revista Medicina |
dc.source.none.fl_str_mv |
reponame:CONICET Digital (CONICET) instname:Consejo Nacional de Investigaciones Científicas y Técnicas |
reponame_str |
CONICET Digital (CONICET) |
collection |
CONICET Digital (CONICET) |
instname_str |
Consejo Nacional de Investigaciones Científicas y Técnicas |
repository.name.fl_str_mv |
CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicas |
repository.mail.fl_str_mv |
dasensio@conicet.gov.ar; lcarlino@conicet.gov.ar |
_version_ |
1846083452576727040 |
score |
13.22299 |